Administration Official to Speak on Value-Based Care

Full access

A senior official in the Trump administration will speak on “The Future of Value-Based Care and Nephrology” in the Christopher R. Blagg, MD, Lectureship in Kidney Diseases and Public Policy on Friday, Nov. 8.

Adam Boehler

The speaker, Adam Boehler, is senior advisor to the secretary of Health and Human Services (HHS), deputy administrator of the Centers for Medicare & Medicaid Services (CMS), and director of the Center for Medicare and Medicaid Innovation (CMMI).

As an advisor on value-based care, Mr. Boehler is co-leading the development of the HHS-wide kidney strategy. He cites as motivation to improve kidney patients’ lives

A senior official in the Trump administration will speak on “The Future of Value-Based Care and Nephrology” in the Christopher R. Blagg, MD, Lectureship in Kidney Diseases and Public Policy on Friday, Nov. 8.

d797570e57

Adam Boehler

Citation: Kidney News 11, 10/11

The speaker, Adam Boehler, is senior advisor to the secretary of Health and Human Services (HHS), deputy administrator of the Centers for Medicare & Medicaid Services (CMS), and director of the Center for Medicare and Medicaid Innovation (CMMI).

As an advisor on value-based care, Mr. Boehler is co-leading the development of the HHS-wide kidney strategy. He cites as motivation to improve kidney patients’ lives his personal experience of seeing his aunt undergo dialysis before she passed away. He has a broad assignment to identify opportunities for policy improvement throughout the department by exploring every possible avenue to advance kidney health, including research and innovation efforts, payment and care delivery models, transplantation-related activity, data integrity and availability, and other activities under HHS’ purview.

In his role as CMMI director, Mr. Boehler has identified kidney care as a top priority for innovation and has worked extensively with ASN and other members of the kidney community to understand opportunities for improvement. He often speaks at healthcare conferences about the burden of kidney diseases and the need to transform patient care.

At the request of ASN, he recently met with committee staff of the U.S. House Appropriations Committee to underscore that KidneyX is a central tenet of the administration’s kidney strategy, a statement of commitment he hoped would increase the likelihood of KidneyX receiving congressional funding.

Mr. Boehler founded and was CEO of several successful large businesses and was a leader at two international investment firms. He was the founder and CEO of Landmark Health, the largest home-based medical group in the country, with more than 1000 employees in the U.S. and India and 80,000 chronic patients under management.

He was an operating partner at Francisco Partners, a $14 billion global investment firm with offices in San Francisco and London. He partnered with Francisco Partners to found Avalon, the leading provider of laboratory benefit management services.

He was a principal at Accretive, a private equity firm based in New York. Prior to joining Accretive, Mr. Boehler was executive vice president at MedeAnalytics, a leading global provider of software-as-a-service (SaaS) analytics. He started MedeAnalytics’ European operation headquartered in London and led product innovation with over 200 engineers in Ukraine and Hungary. He also worked at Battery Ventures, a global technology-focused venture capital firm managing over $2 billion.

Mr. Boehler graduated magna cum laude from the Wharton School of the University of Pennsylvania.

Save